GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹5,617 Cr | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr |
What is the latest Revenue of GLAND PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹5,617 Cr |
| Mar2025 | ₹5,665 Cr |
| Mar2024 | ₹3,625 Cr |
| Mar2023 | ₹4,401 Cr |
| Mar2022 | ₹3,463 Cr |
How is Revenue of GLAND PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,617 Cr | -0.85 | |
| Mar2025 | ₹5,665 Cr | 56.29 | |
| Mar2024 | ₹3,625 Cr | -17.64 | |
| Mar2023 | ₹4,401 Cr | 27.08 | |
| Mar2022 | ₹3,463 Cr | - | |
Compare Revenue of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,775.8 Cr | -0.7% | 0.8% | 44.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.7% |
0.8% |
44.5% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses